Oral, perioral and systemic pathosis in HgCl2-induced autoimmunity in the BN rat.
Male BN rats were repeatedly skin-injected with HgCl2 solution and sacrificed after 6, 9, 14, 21, 28 or 24 days. Mononuclear cell infiltrates were observed in the oral mucosa and in lacrimal, salivary and thyroid glands from 6-9 days onwards, with a peak at 14-21 days. Immunohistochemistry identified these cells as predominantly T cells with some NK cells but very few B cells. Reversible parenchymal changes were observed but there was no obvious persistent tissue destruction. Serum titers of IgE, IgG1, anti-laminin and anti-DNP, but not IgG2a antibodies, were raised and peaked at 14-21 days. However, there was no correlation, within animals, between these titers and the extent of mononuclear cell infiltration. Mercury was histochemically detected within dendritic cells/macrophages in the connective tissue stroma of the glands and in the oral mucosa, but no correlation was found between the distribution of mercury and the degree of inflammation. We conclude that the accumulation of mononuclear cells in oral and perioral tissues of HgCl2-treated BN rats does not represent a local immune response to tissue-retained Hg. Instead, we propose that the extravasation represents an epiphenomenon that is not necessarily deleterious to the infiltrated organ.
Warfvinge
G
G
Department of Oral Pathology, Lund University, Sweden. gunnar.warfvinge@odpatol.lu.se
Peszkowski
M J
MJ
Hultman
P
P
Larsson
A
A
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000032:analysis; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000473:pathology; D001402:B-Lymphocytes / Q000473:pathology; D003238:Connective Tissue / Q000473:pathology; D003713:Dendritic Cells / Q000473:pathology; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007150:Immunohistochemistry; D007249:Inflammation; D007271:Injections, Intradermal; D007694:Killer Cells, Natural / Q000473:pathology; D007766:Lacrimal Apparatus Diseases / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D007797:Laminin / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000473:pathology; D008264:Macrophages / Q000473:pathology; D008297:Male; D008627:Mercuric Chloride / Q000008:administration & dosage / Q000009:adverse effects* / Q000032:analysis; D008628:Mercury / Q000032:analysis; D009059:Mouth Diseases / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D009061:Mouth Mucosa / Q000473:pathology; D051381:Rats; D011914:Rats, Inbred BN; D012466:Salivary Gland Diseases / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D012709:Serum Albumin / Q000032:analysis; D013601:T-Lymphocytes / Q000473:pathology; D013959:Thyroid Diseases / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology
D000891:Anti-Infective Agents, Local; D007074:Immunoglobulin G; D007797:Laminin; D012709:Serum Albumin; D007073:Immunoglobulin E; D008627:Mercuric Chloride; D008628:Mercury